Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Merck Appealing Fraud Ruling

October 1, 2010 6:25 am | by Matthew Perrone | News | Comments

Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said.


Trileptal Costs Novartis $422.5M

October 1, 2010 6:22 am | by Kathy Matheson | News | Comments

Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced.


Knockout Mouse

September 30, 2010 8:30 am | Drug Discovery & Development | Product Releases | Comments

Crescendo Biologics Limited has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The mice are believed to have the immunoglobulin heavy chain, kappa light chain, and lambda light chain loci all functionally silenced.


Protein Discovery

September 30, 2010 8:27 am | Product Releases | Comments

caprotec bioanalytics GmbH announced the commercial launch of three new caproKits, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.


Covance Expands Biotechnology Services

September 30, 2010 8:06 am | News | Comments

Covance Inc. announced the expansion of its biotechnology offerings into North America with the opening of a biotechnology services facility on its Greenfield campus in Indiana.


DaVita Opens Central Lab Facility

September 30, 2010 8:01 am | News | Comments

DaVita Clinical Research has announced the launch of its clinical central lab facility. The over-47,000 square foot facility allows technicians to perform approximately 114,000 tests on 60,000 samples daily.


Synosia Parkinson's Drug Beneficial

September 30, 2010 7:42 am | News | Comments

Synosia Therapeutics announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson’s patients, has a good safety profile and is well tolerated.


New Screening Method Can Identify Drug-Resistant HCV

September 30, 2010 7:29 am | News | Comments

In recent human trials for a promising new class of drug designed to target the hepatitis C virus without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.


Scientists Detail Chemotherapy-induced Brain Changes

September 30, 2010 7:24 am | News | Comments

Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.


Tapentadol ER Compared to Placebo in Phase 3 Trial

September 30, 2010 7:21 am | News | Comments

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online.


Sanofi Loses Patent Fight

September 30, 2010 7:08 am | News | Comments

A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere.


Democrats Want FDA to Initiate Recalls

September 30, 2010 7:06 am | by Matthew Perrone | News | Comments

In spring 2009, a group of contract workers, going mostly to gas station convenience stores, bought up thousands of bottles of Motrin that had been determined to be defective but not dangerous. The workers had been hired for Johnson and Johnson, which wanted to remove the pills from the market without issuing a public recall.


Number of Medicare Plans Covering Brand Names to Triple

September 30, 2010 6:47 am | by Ricardo Alonso-Zaldivar | News | Comments

Seniors with high drug costs will soon have more options to help them cope with Medicare's prescription coverage gap. Reversing a steady decline, the number of prescription plans covering at least some brand-name drugs in the "doughnut hole" will triple next year.


Malawi Adopts UN AIDS Rules

September 30, 2010 6:45 am | News | Comments

Malawi's vice president says her AIDS-ravaged southern African country will adopt the latest U.N. health guidelines that call for putting HIV-positive people on drugs sooner.


J & J CEO to Testify to Congress

September 30, 2010 6:43 am | by Matthew Perrone | News | Comments

The chief executive of Johnson and Johnson will tell Congress his company "let the public down" with a string of quality problems that have resulted in millions of recalled medicines.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.